Michael G Erickson Form 3 IDEXX LABORATORIES / Michael G Erickson ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Erickson Michael G

(Last)

(First)

(Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK

04092

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2024

3. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	10,339.3617	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Unit	⁽¹⁾	⁽¹⁾	Common Stock	108	⁽¹⁾	D
Restricted Stock Unit	⁽²⁾	⁽²⁾	Common Stock	97	⁽²⁾	D
Restricted Stock Unit	⁽³⁾	⁽³⁾	Common Stock	138	⁽³⁾	D
Restricted Stock Unit	⁽⁴⁾	⁽⁴⁾	Common Stock	278	⁽⁴⁾	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Common Stock	377	⁽⁵⁾	D
Restricted Stock Unit	⁽⁶⁾	⁽⁶⁾	Common Stock	1,508	⁽⁶⁾	D
Incentive Stock Option (right-to-buy)	⁽⁷⁾	02/13/2026	Common Stock	1,544	67.85	D
Non-Qualified Stock Option (right-to-buy)	⁽⁸⁾	02/13/2027	Common Stock	1,191	141.6	D
Incentive Stock Option (right-to-buy)	⁽⁹⁾	02/13/2027	Common Stock	719	141.6	D
Non-Qualified Stock Option (right-to-buy)	⁽¹⁰⁾	02/13/2028	Common Stock	4,180	178.26	D
Incentive Stock Option (right-to-buy)	⁽¹¹⁾	02/13/2028	Common Stock	817	178.26	D
Non-Qualified Stock Option (right-to-buy)	⁽¹²⁾	02/13/2029	Common Stock	4,826	206.94	D
Incentive Stock Option (right-to-buy)	⁽¹³⁾	02/13/2029	Common Stock	483	206.94	D
Non-Qualified Stock Option (right-to-buy)	⁽¹⁴⁾	02/13/2030	Common Stock	4,008	288.78	D
Non-Qualified Stock Option (right-to-buy)	⁽¹⁵⁾	02/13/2031	Common Stock	2,468	544.08	D
Incentive Stock Option (right-to-buy)	⁽¹⁶⁾	02/13/2031	Common Stock	183	544.08	D
Non-Qualified Stock Option (right-to-buy)	⁽¹⁷⁾	02/13/2032	Common Stock	3,078	505.53	D
Incentive Stock Option (right-to-buy)	⁽¹⁸⁾	02/13/2032	Common Stock	197	505.53	D
Non-Qualified Stock Option (right-to-buy)	⁽¹⁹⁾	02/13/2033	Common Stock	2,558	497.43	D
Incentive Stock Option (right-to-buy)	⁽²⁰⁾	02/13/2033	Common Stock	201	497.43	D

Explanation of Responses:

1. Grant of 544 restricted stock units ('RSU'). Each RSU represents a contingent right to receive one share of Issuer common stock and vest in five equal annual installments beginning on February 14, 2020.

2. Grant of 390 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2021.

3. Grant of 276 RSUs. Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2022.

4. Grant of 371 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2023.

5. Grant of 377 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2024.

6. Grant of 1,508 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on February 14, 2026.

7. Grant of option to buy 1,544 shares of Issuer common stock that vested on February 14, 2021.

8. Grant of option to buy 1,191 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2018.

9. Grant of option to buy 719 shares of Issuer common stock that vested in one installment on February 14, 2022.

10. Grant of option to buy 4,180 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2019.

11. Grant of option to buy 817 shares of Issuer common stock that vested in one installment on February 14, 2023.

12. Grant of option to buy 4,826 shares of Issuer common stock that vests in five annual installments beginning on February 14, 2020.

13. Grant of option to buy 483 shares of Issuer common stock that vests in one installment on February 14, 2024.

14. Grant of option to buy 4,008 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2021.

15. Grant of option to buy 2,468 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2022.

16. Grant of option to buy 183 shares of Issuer common stock that vests in one installment on February 14, 2025.

17. Grant of option to buy 3,078 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2023.

18. Grant of option to buy 197 shares of Issuer common stock that vests in one installment on February 14, 2026.

19. Grant of option to buy 2,558 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2024.

20. Grant of option to buy 201 shares of Issuer common stock that vests in one installment on February 14, 2027.

Remarks:

	/s/ Michael G. Erickson	01/05/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Michael G Erickson Form 3IDEXX LABORATORIES / Michael G Erickson ownership change